A strong trend toward increased survival was seen in patients with MRSA bacteremia with IL-10 of > 5 pg/ml that received combination therapy compared with those that received monotherapy.
← all excerpts
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
1
—
—